FDA approves the first vaccine for dengue fever, but with major restrictions
The FDA approved the first vaccine against dengue fever, one that protects against a common disease but has generated significant controversy.
The Food and Drug Administration on Wednesday approved the first vaccine against dengue fever, one that protects against a common disease but has generated significant controversy due to evidence it can increase the risk of severe infection in some people.
The agency ruled that Dengvaxia, manufactured by Sanofi Pasteur, can only be used in individuals aged 9 to 16 living in parts of the United States where the
